Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Hutchinson MediPharma Books $7.7 Million from SBCVC Fund

publication date: Dec 21, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Hutchison MediPharma, a division of Chi-Med, raised $7.7 million from Softbank China Venture Capital’s SBCVC Fund III. The second investment in the current round of fund raising, SBCVC’s contribution follows a $12.5 million investment from Mitsui & Co. in November. SBCVC Fund III will receive convertible Preference Shares equivalent to 7.5% of Hutchison MediPharma. More details....

Stock Symbol: (AIM: CHM)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...